Companies / Pathos
Pathos
New York City, New York, United States
Pathos is an AI-enabled, clinical-stage biotech building a new development engine for precision oncology through multimodal data, biological modeling, and biopharma partnerships.
Pathos, based in New York City, New York, United States, has 2 investors on file, among them Lightbank and NEA. Its latest round on record is Series C+, 23 Oct 2026. Its site turns away automated reads, so VCinfo could not check it; it is listed because an investor's own portfolio page links to it.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
2 investors on fileMore from Lightbank
125 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (16%), Healthcare & Biotech (14%), Fintech (14%).
More from NEA
528 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (22%), AI & Machine Learning (19%), Fintech (10%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Pathos and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Lightbank adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/pathos.com/investors
# also
GET /v1/companies/pathos.com
GET /v1/companies/pathos.com/news